pillbase.ru

Элисо

Active substance: taliglucerase alfa

лиофилизат для приготовления концентрата для приготовления раствора для инфузий, 200 ЕД, 200 ЕД (original in Russian, GRLS)

RussiaActive

Marketing holder: Пфайзер Инк

Verified 2026-10-09 · GRLS (Russian state register)

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
US 1
  • ELELYSO
    INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · TALIGLUCERASE ALFA 200 U/5mL
    0069-0106
    Pfizer Laboratories Div Pfizer Inc
EU 1
  • Elelyso
    taliglucerase alfa
    EMEA/H/C/002250
    Pfizer Ltd.   
Import and control

Control by country

  • Russiaprescription only

    Source: GRLS (Russian state register) · record 01a120c3-2fdd-75c7-9d26-a8400d3c20fc,01a120c3-da1e-74b2-87ae-129b044c7e1c;count=2 · valid from 2026-10-09 · verified 2026-10-09

  • United Statesprescription only

    Source: openFDA NDC · record 01a12092-e2d9-7a36-965b-fc9f7ba749f8;count=1 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
ЛП-№(013827)-(ГП-RU)
Registration status
Active
Dispensing
Prescription only
Release forms
лиофилизат для приготовления концентрата для приготовления раствора для инфузий, 200 ЕД, 200 ЕД - флаконы - пачки картонные - По рецепту; (original in Russian, GRLS)
Sources
  • product · GRLS (Russian state register) · ЛП-№(013827)-(ГП-RU) · Verified 2026-10-09
  • registration_status · GRLS (Russian state register) · ЛП-№(013827)-(ГП-RU) · Verified 2026-10-09
  • ingredients.0 · GRLS (Russian state register) · ЛП-№(013827)-(ГП-RU) · Verified 2026-10-09